Experiment ID: 1231

Field Description
namegut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease (11650326) - gpt-5-mini
proj_id11650326
sraprjna917086
date_of_upload15/10/2025 21:08
doi10.1016/j.isci.2024.111442
modelgpt-5-mini

Annotations for experiment:

term enrichment score
TermScore
active disease0.346154
LOWER IN active disease0.216216
irritable bowel syndrome0.103448
adolescent stage0.076923
LOWER IN ileum0.056738
LOWER IN irritable bowel syndrome0.055556
south korea0.052632
ileum0.051383
LOWER IN colon0.046154
ulcerative colitis0.044521
LOWER IN crohn's disease0.044199
colon0.043243
crohn's disease0.042623
LOWER IN ulcerative colitis0.042328
LOWER IN control0.004471
control0.004405
homo sapiens0.002591
feces0.002294
Fraction of dbbact annotations with this term covered by the query
TermScore
active disease0.333333
LOWER IN active disease0.333333
LOWER IN irritable bowel syndrome0.090909
irritable bowel syndrome0.090909
adolescent stage0.040000
LOWER IN ileum0.034483
LOWER IN colon0.028571
ileum0.027027
south korea0.027027
LOWER IN crohn's disease0.025641
LOWER IN ulcerative colitis0.024390
ulcerative colitis0.023256
colon0.022222
crohn's disease0.022222
LOWER IN control0.002278
control0.002227
homo sapiens0.001297
feces0.001148
Exp. ID User ID Description Date Region Sequences Status Flag
1231naActive IBD (CD-act + UC-act) vs IBD in remission (CD-rem + UC-rem) ( high in new-onset or recurrent active ibd active disease compared to mucosal remission clinical remission in feces homo sapiens ileum south korea adolescent stage colon ulcerative colitis crohn's disease )2025-10-15v31 / 3pendingNo
1231naActive IBD (CD-act + UC-act) vs IBD in remission (CD-rem + UC-rem) ( high in mucosal remission clinical remission compared to new-onset or recurrent active ibd active disease in feces homo sapiens ileum south korea adolescent stage colon ulcerative colitis crohn's disease )2025-10-15v31 / 3pendingNo
1231naAnti-TNF treated patients vs active IBD (to assess treatment-associated microbiome shifts) ( high in new-onset or recurrent active ibd active disease compared to received anti-tumor necrosis factor alpha therapy anti-tnf-alpha in feces homo sapiens ileum south korea adolescent stage colon ulcerative colitis crohn's disease )2025-10-15v31 / 3pendingNo
1231naActive Ulcerative Colitis (UC-act) (dominant feces, homo sapiens, new-onset or recurrent active ibd, south korea, adolescent stage, colon, ulcerative colitis, active disease)2025-10-15v31 / 16pendingNo
1231naFunctional gastrointestinal disorder (FGID) / FGD (feces) (dominant colon, feces, homo sapiens, south korea, adolescent stage, irritable bowel syndrome)2025-10-15v31 / 18pendingNo
1231naHealthy controls (HC / Control fecal samples) (dominant control, feces, homo sapiens, south korea, adolescent stage)2025-10-15v31 / 20pendingNo
1231naUlcerative Colitis in remission (UC-rem) (dominant feces, homo sapiens, mucosal remission, south korea, adolescent stage, colon, ulcerative colitis, clinical remission)2025-10-15v31 / 21pendingNo
1231naPatients who received anti-TNF-alpha (any state) (dominant received anti-tumor necrosis factor alpha therapy, feces, homo sapiens, anti-tnf-alpha, ileum, south korea, adolescent stage, colon, ulcerative colitis, crohn's disease)2025-10-15v31 / 23pendingNo
1231naCrohn’s disease in remission (CD-rem) (dominant feces, homo sapiens, mucosal remission, ileum, south korea, adolescent stage, colon, clinical remission, crohn's disease)2025-10-15v31 / 24pendingNo
1231naActive Crohn’s disease (CD-act) (common feces, homo sapiens, new-onset or recurrent active ibd, ileum, south korea, adolescent stage, colon, active disease, crohn's disease)2025-10-15v31 / 28pendingNo
1231naActive Crohn’s disease (CD-act) (dominant feces, homo sapiens, new-onset or recurrent active ibd, ileum, south korea, adolescent stage, colon, active disease, crohn's disease)2025-10-15v31 / 28pendingNo
1231naCrohn’s disease in remission (CD-rem) (common feces, homo sapiens, mucosal remission, ileum, south korea, adolescent stage, colon, clinical remission, crohn's disease)2025-10-15v31 / 32pendingNo
1231naPatients who received anti-TNF-alpha (any state) (common received anti-tumor necrosis factor alpha therapy, feces, homo sapiens, anti-tnf-alpha, ileum, south korea, adolescent stage, colon, ulcerative colitis, crohn's disease)2025-10-15v31 / 32pendingNo
1231naActive Ulcerative Colitis (UC-act) (common feces, homo sapiens, new-onset or recurrent active ibd, south korea, adolescent stage, colon, ulcerative colitis, active disease)2025-10-15v31 / 33pendingNo
1231naUlcerative Colitis in remission (UC-rem) (common feces, homo sapiens, mucosal remission, south korea, adolescent stage, colon, ulcerative colitis, clinical remission)2025-10-15v31 / 47pendingNo
1231naFunctional gastrointestinal disorder (FGID) / FGD (feces) (common colon, feces, homo sapiens, south korea, adolescent stage, irritable bowel syndrome)2025-10-15v31 / 51pendingNo
1231naIBD (all states) vs Functional gastrointestinal disorder (FGID) ( high in irritable bowel syndrome compared to mucosal remission new-onset or recurrent active ibd ileum ulcerative colitis clinical remission active disease crohn's disease in feces homo sapiens south korea adolescent stage colon )2025-10-15v31 / 56pendingNo
1231naIBD (all states) vs Functional gastrointestinal disorder (FGID) ( high in mucosal remission new-onset or recurrent active ibd ileum ulcerative colitis clinical remission active disease crohn's disease compared to irritable bowel syndrome in feces homo sapiens south korea adolescent stage colon )2025-10-15v31 / 57pendingNo
1231naHealthy controls (HC / Control fecal samples) (common control, feces, homo sapiens, south korea, adolescent stage)2025-10-15v31 / 61pendingNo
1231naPatients who received anti-TNF-alpha vs Healthy controls ( high in control compared to received anti-tumor necrosis factor alpha therapy anti-tnf-alpha ileum colon ulcerative colitis crohn's disease in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 72pendingNo
1231naPatients who received anti-TNF-alpha vs Healthy controls ( high in received anti-tumor necrosis factor alpha therapy anti-tnf-alpha ileum colon ulcerative colitis crohn's disease compared to control in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 75pendingNo
1231naActive IBD (CD-act + UC-act) vs Healthy controls ( high in new-onset or recurrent active ibd ileum colon ulcerative colitis active disease crohn's disease compared to control in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 94pendingNo
1231naActive IBD (CD-act + UC-act) vs Healthy controls ( high in control compared to new-onset or recurrent active ibd ileum colon ulcerative colitis active disease crohn's disease in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 97pendingNo
1231naAll IBD (CD-act + CD-rem + UC-act + UC-rem) vs Healthy controls ( high in control compared to mucosal remission new-onset or recurrent active ibd ileum colon ulcerative colitis clinical remission active disease crohn's disease in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 113pendingNo
1231naAll IBD (CD-act + CD-rem + UC-act + UC-rem) vs Healthy controls ( high in mucosal remission new-onset or recurrent active ibd ileum colon ulcerative colitis clinical remission active disease crohn's disease compared to control in adolescent stage feces south korea homo sapiens )2025-10-15v31 / 116pendingNo

Problems / suggestions? Please visit the dbBact forum